International Stem Cell Corporation Offers a Possible Alternative to Animal Corneal Testing
Please take a moment to listen to International Stem Cell Corporation Chairman, Ken Aldrich, as he discusses the benefits of using human corneas developed in Petri dishes as an alternative to testing on the eyes of innocent rabbits.
This is Ken Aldrich and I am chairman of International Stem Cell Corporation and I am here to talk to you a little bit about rabbits. One of the things that most people don’t know is that cosmetic companies, drug companies and pesticide makers all have to test their products to see whether they do damage to the human eye. Unfortunately, the way they do it is to take poor innocent rabbi...
Source: International Stem Cell Corporation - April 16, 2009 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell animal testing human cornea Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laboratory animals curren...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborato...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laboratory animals curren...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborato...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
International Stem Cell Corporation Announces a Manufacturing and Supply Agreement with Millipore Co
International Stem Cell (OTCBB:ISCO) announced today it has entered into a worldwide distribution agreement with Millipore Corporation (NYSE: MIL) to manufacture living cells and cell culture products to be sold through Millipore’s distribution network.
“To work with a company such as Millipore that has sales of over $1.5 billion and is known throughout the world is a wonderful opportunity for ISCO. This partnership will lead to a significant expansion in ISCO’s revenue generation through the manufacture of high quality cells and cell culture products. Millipore is a leader in the life science industry, with a strong...
Source: International Stem Cell Corporation - September 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
